These pleiotropic anti-i nflammatory and anti-fibrotic actions of DPP-4 inhibitors are not analogous to those of the standard anti-i nflammatory agents (such as corticosteroids) and may provide a helpful tool in COVID-19 therapy owing to their other positive actions.109. This evidence concerns the gene DPP4 and COVID-19.